Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
Rodrigues Carvalho
S
S
Silva
I
I
Leiria-Pinto
P
P
Rosado-Pinto
J
J
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004977:Ethambutol / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D012882:Skin Tests; D013307:Streptomycin / Q000008:administration & dosage / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin